Lexicon Pharmaceuticals (LXRX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Lexicon Pharmaceuticals (LXRX) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.10 of bullish evidence against -0.36 bearish.

Lexicon Pharmaceuticals last closed at $1.74, -4.40% on the session.

Against the IVW growth benchmark the position is -5.32% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

Lexicon Pharmaceuticals has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Lexicon Pharmaceuticals in the 20th percentile on return on equity, where 100 is best.

Lexicon Pharmaceuticals is classified under Health Care / Pharmaceuticals, with a market capitalisation of $809.82M.

StockMap tracks Lexicon Pharmaceuticals as the 58th largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite Lexicon Pharmaceuticals ranks 83rd of 128 in the group, against a group median of -0.24.